Crinetics Pharmaceuticals, Inc.
CRNX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $111 | $54 | $95 | $265 |
| Short-Term Investments | $981 | $1,143 | $1,180 | $1,090 |
| Receivables | $0 | $0 | $7 | $8 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $29 | $21 | $10 | $13 |
| Total Curr. Assets | $1,121 | $1,217 | $1,291 | $1,375 |
| Property Plant & Equip (Net) | $56 | $57 | $55 | $56 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $1 | $0 | $2 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $19 | $15 | $15 | $2 |
| Total NC Assets | $75 | $72 | $70 | $59 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,196 | $1,290 | $1,361 | $1,435 |
| Liabilities | – | – | – | – |
| Payables | $6 | $11 | $10 | $6 |
| Short-Term Debt | $6 | $7 | $7 | $7 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $2 | $2 | $2 |
| Other Curr. Liab. | $62 | $49 | $38 | $45 |
| Total Curr. Liab. | $74 | $68 | $57 | $60 |
| LT Debt | $43 | $43 | $44 | $45 |
| Deferred Rev, NC | $0 | $4 | $4 | $5 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $7 | $2 | $2 | $1 |
| Total NC Liab. | $50 | $50 | $50 | $50 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $49 | $50 | $51 | $52 |
| Total Liabilities | $124 | $118 | $107 | $110 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $2,365 | $2,335 | $2,301 | $2,276 |
| Retained Earnings | -$1,295 | -$1,165 | -$1,049 | -$952 |
| AOCI | $2 | $2 | $2 | $1 |
| Other Equity | $0 | -$0 | $0 | $0 |
| Total Equity | $1,072 | $1,172 | $1,254 | $1,325 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,196 | $1,290 | $1,361 | $1,435 |
| Net Debt | -$62 | -$4 | -$44 | -$213 |